Piramal Pharma Limited (BOM:543635)

India flag India · Delayed Price · Currency is INR
180.55
-1.55 (-0.85%)
At close: Dec 4, 2025
-31.74%
Market Cap 238.81B
Revenue (ttm) 89.36B
Net Income (ttm) -237.40M
Shares Out n/a
EPS (ttm) -0.18
PE Ratio n/a
Forward PE 101.91
Dividend 0.14 (0.08%)
Ex-Dividend Date Jul 16, 2025
Volume 183,509
Average Volume 145,312
Open 182.05
Previous Close 182.10
Day's Range 179.55 - 182.55
52-Week Range 179.55 - 279.20
Beta n/a
RSI 29.03
Earnings Date Nov 5, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, inje... [Read more]

Industry Pharmaceutical Preparations
Founded 2020
Employees 5,476
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543635
Full Company Profile

Financial Performance

In 2024, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.

Financial Statements

News

There is no news available yet.